Develops and manufactures recombinant protein therapeutics and microecological preparations for antiviral, oncology, immune, hematology, digestive and degenerative disease treatment. Builds platforms for novel proteins, antibodies and nucleic‑acid drugs and advances applications in animal vaccines, synthetic organisms and phage for broader health use.